Cargando…

Voriconazole Provides Effective Prophylaxis for Invasive Fungal Infection in Patients Receiving Glucocorticoid Therapy for Graft-Versus-Host Disease

Patients on systemic glucocorticoids for graft-versus-host disease (GVHD) after hematopoietic cell transplant are susceptible to invasive fungal infections (IFI), which greatly contribute to morbidity and mortality. We evaluated the efficacy of prophylactic treatment options (voriconazole versus flu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gergis, Usama, Markey, Kelly, Greene, John, Kharfan-Dabaja, Mohamed, Field, Teresa, Wetzstein, Gene, Schell, Michael J., Huang, Yifan, Anasetti, Claudio, Perkins, Janelle
Formato:	Texto
Lenguaje:	English
Publicado:	2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850960/ https://www.ncbi.nlm.nih.gov/pubmed/19684623 http://dx.doi.org/10.1038/bmt.2009.210

Ejemplares similares

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
por: Pidala, Joseph, et al.
Publicado: (2010)

742. Breakthrough Invasive Fungal Infections with Isavuconazonium Sulfate versus Voriconazole as Primary Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia (AML) who Received Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

755. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
por: Almutairy, Reem F, et al.
Publicado: (2020)

Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
por: Agrawal, Vaibhav, et al.
Publicado: (2020)

Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy
por: Sadat-Ali, Mir, et al.
Publicado: (2009)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018)

Voriconazole in the management of nosocomial invasive fungal infections
por: Pemán, Javier, et al.
Publicado: (2006)

Topical and Oral Voriconazole in the Treatment of Fungal Keratitis
por: Lee, Sang Joon, et al.
Publicado: (2009)

Voriconazole-refractory fungal infection of phacoemulsification tunnel
por: Mittal, Vikas, et al.
Publicado: (2010)

Ineffectiveness of intrastromal voriconazole for filamentous fungal keratitis
por: Niki, Masanori, et al.
Publicado: (2014)

Primary or Secondary Prophylaxis with Voriconazole Compared with Posaconazole for Prevention of Invasive Fungal Infections After Hematopoietic Stem Cell Transplantation
por: Jansen, Jeffrey W, et al.
Publicado: (2017)

2112. Voriconazole for Primary Prophylaxis: A Decade of Trends and Outcomes
por: Mourad, Ahmad, et al.
Publicado: (2019)

Update on the optimal use of voriconazole for invasive fungal infections
por: Lat, Asma, et al.
Publicado: (2011)

Voriconazole Treatment for Fungal Chorioretinitis After Obesity Surgery
por: Savur, Fatma, et al.
Publicado: (2021)

Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population
por: Kharfan-Dabaja, Mohamed A., et al.
Publicado: (2009)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011)

Comparative study of prophylaxis with high and low doses of voriconazole in children with malignancy
por: L. Kandaurava, Sviatlana, et al.
Publicado: (2020)

The Use of Voriconazole as Primary Prophylaxis for Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation: A Single Center’s Experience
por: Atoui, Ali, et al.
Publicado: (2021)

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
por: Grau, Santiago, et al.
Publicado: (2015)

Treatment of chronic invasive fungal sinusitis with voriconazole in an HIV patient
por: Ho, A, et al.
Publicado: (2010)

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis
por: Al-Badriyeh, Daoud, et al.
Publicado: (2010)

Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis
por: Malhotra, Sakshi, et al.
Publicado: (2014)

Corneal Debridement Combined with Intrastromal Voriconazole for Recalcitrant Fungal Keratitis
por: Sun, Yajie, et al.
Publicado: (2018)

Efficacy of Voriconazole Corneal Intrastromal Injection for the Treatment of Fungal Keratitis
por: Li, Chenshuang, et al.
Publicado: (2021)

Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
por: Cai, Jingjing, et al.
Publicado: (2023)

Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and Voriconazole
por: Hall, Victoria G, et al.
Publicado: (2023)

Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis
por: Zhong, Jing, et al.
Publicado: (2018)

1301. Breakthrough Invasive Fungal Infections based on CYP2C19 Levels in Patients Who were on Voriconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) undergoing Induction Chemotherapy
por: Singam, Hareesh v, et al.
Publicado: (2020)

Paecilomyces Pneumonia Despite Voriconazole Prophylaxis: A Case Report and Literature Review
por: Asif, Abuzar A, et al.
Publicado: (2021)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
por: Jia, Su-jie, et al.
Publicado: (2021)

Combination of Intracameral and Intrastromal Voriconazole in the Treatment of Recalcitrant Acremonium Fungal Keratitis
por: Haddad, Randa S., et al.
Publicado: (2012)

Successful treatment of an invasive fungal infection caused by Talaromyces sp. with voriconazole
por: Sili, Uluhan, et al.
Publicado: (2015)

Intrastromal voriconazole as successful adjunctive approach for recalcitrant deep fungal keratitis
por: Bhirud, Atul, et al.
Publicado: (2023)

Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections
por: de Almeida Campos, Laís, et al.
Publicado: (2023)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
por: Rafei, Hind, et al.
Publicado: (2017)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

Voriconazole as a secondary prophylaxis for cryptococcal meningitis during hematopoietic stem cell transplantation
por: Kashima, Emiko, et al.
Publicado: (2021)

Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia
por: Tu, Songji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jhan148ojkqpgnk6ddn7tdmj4h